11 research outputs found

    The relationship between sulfur metabolism and tolerance of hexavalent chromium in Scenedesmus acutus (Spheropleales): Role of ATP sulfurylase

    Get PDF
    Sulfur availability and the end products of its metabolism, cysteine, glutathione and phytochelatins, play an important role in heavy metal tolerance, chromium included. Sulfate and chromate not only compete for the transporters but also for assimilation enzymes and chromium tolerance in various organisms has been associated to differences in this pathway. We investigated the mechanisms of Cr(VI)-tolerance increase induced by S-starvation focusing on the role of ATP sulfurylase (ATS) in two strains of Scenedesmus acutus with different chromium sensitivity. S-starvation enhances the defence potential by increasing sulfate uptake/assimilation and decreasing chromium uptake, thus suggesting a change in the transport system. We isolated two isoforms of the enzyme, SaATS1 and SaATS2, with different sensitivity to sulfur availability, and analysed them in S-sufficient and S-replete condition both in standard and in chromium supplemented medium. SaATS2 expression is different in the two strains and presumably marks a different sulfur perception/exploitation in the Cr-tolerant. Its induction and silencing are compatible with a role in the transient tolerance increase induced by S-starvation. This enzyme can however hardly be responsible for the large cysteine production of the Cr-tolerant strain after starvation, suggesting that cytosolic rather than chloroplastic cysteine production is differently regulated in the two strains

    The Proton Activation Data File PADF-2007

    No full text
    To satisfy the increasing needs of nuclear data at intermediate energies the Proton Activation Data File (PADF-2007) has been generated. It contains 418,575 excitation functions of nuclear reactions for 2355 target nuclei from Mg to Ra at proton energies up to 150 MeV. The data are given for stable and unstable target nuclei including isomeric targets with half-lifes more than one second. The cross sections were obtained on the basis of model calculations using the TALYS and the ALICE/ASH codes and available experimental data

    A new approach to macroalgal bloom control in eutrophic, shallow-water, coastal areas

    No full text
    In summer 2012, an experiment was conducted in a shallow eutrophic lagoon with poor water exchange to determine the consequences of harvesting algae on the algal mat itself, which was traversed and repeatedly disturbed by large harvester boats. Four areas with high macroalgal density, measuring half a hectare each, were selected. Two were subjected to frequent disturbance of the algal mat and sediment (12 two-hour operations over a 38-day period) and the other two were left undisturbed as control. The following variables were determined: 1) water column physical chemistry and nutrients; 2) redox potential, nutrients and organic load in sediments; 3) C, N and P content of algal thalli; 4) macroalgal biomass. In 2013, a further experiment was conducted on a larger scale. Biomass was estimated in a highdensity mat measuring 235 ha, where macroalgae were harvested and stirred up by four harvesting boats, and in two high-density mats measuring 150 and 120 ha, left undisturbed as control (9.15, 9.92 and 3.68 kg/m2, respectively). In the first experiment, no significant changes were observed in the water column. In sediment the main variation was a significant reduction in labile organic matter in the disturbed areas and a significant increase mainly in refractory organic matter in the undisturbed areas. Biomass showed a significant drastic reduction in disturbed areas and substantial stability in undisturbed areas. In the large-scale experiment, the biomass of the disturbed mat declined by about 63%, only 6.5% of which was due to harvesting. On the other hand, the undisturbed mat with higher density underwent a natural decline in biomass of about 23% and the other increased by about 50%. These results demonstrate that disturbance of high-density mat in shallow water by boats can cause decay of the mat

    Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

    No full text
    BACKGROUND: We studied the genetic fingerprints of ovarian cancer and validated the potential of Mammaglobin b (SCGB2A1), one of the top differentially expressed genes found in our analysis, as a novel ovarian tumour rejection antigen. METHODS: We profiled 70 ovarian carcinomas including 24 serous (OSPC), 15 clear-cell (CC), 24 endometrioid (EAC) and 7 poorly differentiated tumours, and 14 normal human ovarian surface epithelial (HOSE) control cell lines using the Human HG-U133 Plus 2.0 chip (Affymetrix). Quantitative real-time PCR and immunohistochemistry staining techniques were used to validate microarray data at RNA and protein levels for SCGB2A1. Full-length human-recombinant SCGB2A1 was used to pulse monocyte-derived dendritic cells (DCs) to stimulate autologous SCGB2A1-specific cytotoxic T-lymphocyte (CTL) responses against chemo-naive and chemo-resistant autologous ovarian tumours. RESULTS: Gene expression profiling identified SCGB2A1 as a top differentially expressed gene in all histological ovarian cancer types tested. The CD8+ CTL populations generated against SCGB2A1 were able to consistently induce lysis of autologous primary (chemo-naive) and metastatic/recurrent (chemo-resistant) target tumour cells expressing SCGB2A1, whereas autologous HLA-identical noncancerous cells were not lysed. Cytotoxicity against autologous tumour cells was significantly inhibited by anti-HLA-class I (W6/32) monoclonal antibody. Intracellular cytokine expression measured by flow cytometry showed a striking type 1 cytokine profile (i.e., high IFN-Îł secretion) in SCGB2A1-specific CTLs. CONCLUSION: SCGB2A1 is a top differentially expressed gene in all major histological types of ovarian cancers and may represent a novel and attractive target for the immunotherapy of patients harbouring recurrent disease resistant to chemotherapy
    corecore